Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof

Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof

US Patent 11242351 · Granted Feb 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
Amide-based proteolysis modulators of B-rapidly accelerated fibrosarcoma (BRAF) 2025
Heterocyclic acyl hydrazone linkers, methods and uses thereof2023
Heterocyclic acyl hydrazone linkers, methods and uses thereof2023
Acyl hydrazone linkers, methods and uses thereof2023
Acyl hydrazone linkers, methods and uses thereof2023